Literature DB >> 34942107

Association Between Fluid Volume in Inner Nuclear Layer and Visual Acuity in Diabetic Macular Edema.

Kotaro Tsuboi1, Qi Sheng You2, Yukun Guo1, Jie Wang3, Christina J Flaxel1, Steven T Bailey1, David Huang1, Yali Jia3, Thomas S Hwang4.   

Abstract

PURPOSE: In diabetic macular edema (DME), the correlation between visual acuity (VA) and central subfield thickness (CST) is weak. We hypothesize that fluid volume (FV) in the inner nuclear layer (INL) may correlate more strongly with VA.
DESIGN: Retrospective, cross-sectional study.
METHODS: One eye each of diabetic patients with DME was included. We measured intraretinal fluid volume that was detected by automated fluid detection algorithm on 3- × 3-mm optical coherence tomography angiogram volume scans. The detected fluid was subdivided into inner FV, bounded by the INL, and outer FV, the fluid between the outer border of INL to the ellipsoid zone.
RESULTS: We enrolled 125 patients with DME (60 women; mean age, 61 years). The mean detected inner FV was 0.013 mm3 in 109 eyes (87%). The mean detected outer FV was 0.042 mm3 in 124 eyes (99%). Univariate analysis demonstrated that the VA significantly correlated with the inner FV (P < .0001), whole macular FV (P = .010), and CST (P = .036). Multivariate analysis demonstrated that the inner FV was the only significant factor (β = -0.41, P = .004). These correlations were consistent when the treatment-naïve group (n = 33) and the eyes without previous laser treatments (n = 93) were analyzed separately. The area under the receiver operating characteristic curve of inner FV for VA of 20/32 or worse was significantly higher than that for CST (0.66 vs 0.54, P = .018).
CONCLUSIONS: The inner FV has a stronger association with VA than other OCT biomarkers in DME and may be more clinically useful.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34942107      PMCID: PMC9035073          DOI: 10.1016/j.ajo.2021.12.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  47 in total

1.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

2.  Advanced image processing for optical coherence tomographic angiography of macular diseases.

Authors:  Miao Zhang; Jie Wang; Alex D Pechauer; Thomas S Hwang; Simon S Gao; Liang Liu; Li Liu; Steven T Bailey; David J Wilson; David Huang; Yali Jia
Journal:  Biomed Opt Express       Date:  2015-11-02       Impact factor: 3.732

3.  Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.

Authors:  Raafay Sophie; Na Lu; Peter A Campochiaro
Journal:  Ophthalmology       Date:  2015-04-11       Impact factor: 12.079

4.  Automated volumetric segmentation of retinal fluid on optical coherence tomography.

Authors:  Jie Wang; Miao Zhang; Alex D Pechauer; Liang Liu; Thomas S Hwang; David J Wilson; Dengwang Li; Yali Jia
Journal:  Biomed Opt Express       Date:  2016-03-30       Impact factor: 3.732

5.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Patterns of diabetic macular edema with optical coherence tomography.

Authors:  T Otani; S Kishi; Y Maruyama
Journal:  Am J Ophthalmol       Date:  1999-06       Impact factor: 5.258

7.  Computational image analysis for prognosis determination in DME.

Authors:  Bianca S Gerendas; Hrvoje Bogunovic; Amir Sadeghipour; Thomas Schlegl; Georg Langs; Sebastian M Waldstein; Ursula Schmidt-Erfurth
Journal:  Vision Res       Date:  2017-05-09       Impact factor: 1.886

8.  Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Authors:  David M Brown; Quan Dong Nguyen; Dennis M Marcus; David S Boyer; Sunil Patel; Leonard Feiner; Patricio G Schlottmann; Amy Chen Rundle; Jiameng Zhang; Roman G Rubio; Anthony P Adamis; Jason S Ehrlich; J Jill Hopkins
Journal:  Ophthalmology       Date:  2013-05-22       Impact factor: 12.079

9.  Macular thickness assessment in healthy eyes based on ethnicity using Stratus OCT optical coherence tomography.

Authors:  Patrick J Kelty; John F Payne; Rupal H Trivedi; Jason Kelty; Esther M Bowie; Berdine M Burger
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06       Impact factor: 4.799

10.  Comparison of Central Macular Fluid Volume With Central Subfield Thickness in Patients With Diabetic Macular Edema Using Optical Coherence Tomography Angiography.

Authors:  Qi Sheng You; Kotaro Tsuboi; Yukun Guo; Jie Wang; Christina J Flaxel; Steven T Bailey; David Huang; Yali Jia; Thomas S Hwang
Journal:  JAMA Ophthalmol       Date:  2021-07-01       Impact factor: 7.389

View more
  1 in total

1.  OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.

Authors:  Jingxin Zhou; Siyuan Song; Yi Zhang; Kai Jin; Juan Ye
Journal:  Ophthalmol Ther       Date:  2022-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.